The U.S. Food and Drug Administration has issued new guidance for organizations using electronic health record data for FDA-regulated clinical trials, GovInfoSecurity reports. Included in the guidance, titled "Use of Electronic Health Record Data in Clinical Investigations: Guidance for Industry," are requirements to ensure EHRs have privacy and security controls in place. If EHR data is collected from "foreign" sources, groups need to think about whether such sources have "certain privacy and security controls in place to ensure that the confidentiality, integrity and security of data are preserved," according to the FDA. 
Full Story